Profound Medical Corp.PROFNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank51
5Y CAGR-24.7%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-24.7%/yr
Long-term compound
Percentile
P51
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.40% |
| Q3 2025 | 136.56% |
| Q2 2025 | -15.64% |
| Q1 2025 | -50.79% |
| Q4 2024 | 39.09% |
| Q3 2024 | 71.54% |
| Q2 2024 | 55.15% |
| Q1 2024 | -45.94% |
| Q4 2023 | 54.04% |
| Q3 2023 | 7.87% |
| Q2 2023 | -13.88% |
| Q1 2023 | 9.30% |
| Q4 2022 | -39.45% |
| Q3 2022 | 39.99% |
| Q2 2022 | 17.74% |
| Q1 2022 | 35.13% |
| Q4 2021 | -60.73% |
| Q3 2021 | 23.39% |
| Q2 2021 | 191.49% |
| Q1 2021 | -75.62% |
| Q4 2020 | 63.74% |
| Q3 2020 | 118.13% |
| Q2 2020 | -11.55% |
| Q1 2020 | -46.49% |
| Q4 2019 | 320.63% |
| Q3 2019 | 17.84% |
| Q2 2019 | -60.43% |
| Q1 2019 | -9.34% |
| Q4 2018 | 418.72% |
| Q3 2018 | 44.89% |
| Q2 2018 | -44.34% |
| Q1 2018 | -80.18% |
| Q4 2017 | 24.49% |
| Q3 2017 | 60.51% |
| Q2 2017 | 65.92% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |